146 related articles for article (PubMed ID: 8285618)
1. In vitro activity of Bay y 3118, a new quinolone.
Fass RJ
Antimicrob Agents Chemother; 1993 Nov; 37(11):2348-57. PubMed ID: 8285618
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of BAY 12-8039, a new fluoroquinolone.
Woodcock JM; Andrews JM; Boswell FJ; Brenwald NP; Wise R
Antimicrob Agents Chemother; 1997 Jan; 41(1):101-6. PubMed ID: 8980763
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of CS-940, a new trifluorinated quinolone.
Biedenbach DJ; Sutton LD; Jones RN
Antimicrob Agents Chemother; 1995 Oct; 39(10):2325-30. PubMed ID: 8619590
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds.
Barrett MS; Jones RN; Erwin ME
Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):134-41. PubMed ID: 8388792
[TBL] [Abstract][Full Text] [Related]
5. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Bauernfeind A
J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398
[TBL] [Abstract][Full Text] [Related]
6. The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.
Wise R; Andrews JM; Brenwald N
J Antimicrob Chemother; 1993 Jan; 31(1):73-80. PubMed ID: 8383104
[TBL] [Abstract][Full Text] [Related]
7. Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Feb; 38(2):369-70. PubMed ID: 8192468
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
Hosaka M; Yasue T; Fukuda H; Tomizawa H; Aoyama H; Hirai K
Antimicrob Agents Chemother; 1992 Oct; 36(10):2108-17. PubMed ID: 1332587
[TBL] [Abstract][Full Text] [Related]
9. Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Dec; 41(12):2786-9. PubMed ID: 9420061
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone.
Fass RJ
Antimicrob Agents Chemother; 1997 Aug; 41(8):1818-24. PubMed ID: 9257770
[TBL] [Abstract][Full Text] [Related]
11. A multicenter comparative study of the in vitro activity of fleroxacin and other antimicrobial agents.
Markowitz SM; Williams DS; Hanna CB; Parker JL; Pierce MA; Steele JC
Chemotherapy; 1995; 41(6):477-86. PubMed ID: 8529440
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of four new fluoroquinolones.
García-Rodríguez JA; García Sánchez JE; García García MI; Fresnadillo MJ; Trujillano I; García Sánchez E
J Antimicrob Chemother; 1994 Jul; 34(1):53-64. PubMed ID: 7961215
[TBL] [Abstract][Full Text] [Related]
13. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin.
Fung-Tomc J; Minassian B; Kolek B; Washo T; Huczko E; Bonner D
J Antimicrob Chemother; 2000 Apr; 45(4):437-46. PubMed ID: 10747819
[TBL] [Abstract][Full Text] [Related]
16. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.
Bongaerts GP; Hoogkamp-Korstanje JA
Antimicrob Agents Chemother; 1993 Sep; 37(9):2017-9. PubMed ID: 8239624
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.
Bremm KD; Petersen U; Metzger KG; Endermann R
Chemotherapy; 1992; 38(6):376-87. PubMed ID: 1288961
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.
Dalhoff A; Petersen U; Endermann R
Chemotherapy; 1996; 42(6):410-25. PubMed ID: 8957575
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
Sato K; Hoshino K; Tanaka M; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1992 Jul; 36(7):1491-8. PubMed ID: 1324647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
